NasdaqCM

HURA

hVIVO plc operates as a pharmaceutical service and contract research company specializing in testing vaccines and antivirals through human challenge clinical trials and providing laboratory services such as assay development, molecular, immunology, virology, clinical trial logistics, and biomarker analysis. The company offers a portfolio of human challenge study models for various conditions and supports pre-clinical and clinical respiratory drug and vaccine discovery and development, along with drug development consultancy and related services for big pharma and biotech organizations.

HVO.L

MindWalk Holdings Corp. operates as a bio-native AI company focused on integrating artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics. Through its LensAI platform and HYFT technology, it partners with pharmaceutical and biotechnology companies to drive de-risk drug development and unlock therapeutic possibilities.

HYFT

Hyperion DeFi, Inc. develops and commercializes ophthalmic solutions, including a topical ophthalmic medication dispensing platform called Optejet, and holds multiple license agreements to develop and commercialize ophthalmic products such as MicroPine, MicroLine, Mydcombi, and Clobetasol Propionate Ophthalmic Suspension for treating eye conditions in various international markets.

HYPD

NYSE American

IBIO

NasdaqGS

IBRX

ICCC

IDYA

IFRX

ImageneBio, Inc. develops therapeutics for immunological and inflammatory diseases, with its lead product IMG-007, a non-depleting anti-OX40 mAb that has completed Phase 2a clinical trials for treating atopic dermatitis and alopecia areata.

IMCR

ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease. Its other product candidates include BioAMB, a peptide-based drug for the treatment of Amphotericin-B formulations, a fungal infection caused by the aspergillus family of fungi; and BioCin, a peptide-based antibacterial drug used in high medical need cases and in last line of defense. The company has a collaboration arrangement with Centre National de la Recherche Scientifique for the development of a peptide technology platform for treating diabetes with glucagon-like peptide -1 agonists, as well as development of peptides as glucagon antagonists to treat type I and type II diabetes; and license and development agreement with Avion Pharmaceuticals LLC. ImmuPharma plc was founded in 1999 and is headquartered in London, the United Kingdom.

Symbol	Full Name	Sector	Industry	YTD Return	10Y Return (Annualized)	Dividend Yield	Risk / Return Rank
HURA	TuHURA Biosciences, Inc.	Healthcare	Biotechnology	86.34%	-66.22%	0.00%	22
HVO.L	hVIVO PLC	Healthcare	Biotechnology	1.59%	-11.70%	3.12%	17
HYFT	MindWalk Holdings Corp	Healthcare	Biotechnology	-37.36%	—	0.00%	83
HYPD	Hyperion DeFi, Inc	Healthcare	Biotechnology	-8.71%	—	0.00%	77
IBIO	iBio, Inc.	Healthcare	Biotechnology	2.59%	-51.84%	0.00%	28
IBRX	ImmunityBio, Inc.	Healthcare	Biotechnology	268.69%	-2.82%	0.00%	81
ICCC	ImmuCell Corporation	Healthcare	Biotechnology	4.72%	-0.40%	0.00%	53
IDYA	IDEAYA Biosciences, Inc.	Healthcare	Biotechnology	-5.29%	—	0.00%	89
IFRX	InflaRx N.V.	Healthcare	Biotechnology	-9.66%	—	0.00%	38
IKT	Inhibikase Therapeutics, Inc.	Healthcare	Biotechnology	-12.20%	—	0.00%	31
IMA	ImageneBio, Inc	Healthcare	Biotechnology	-27.97%	—	0.00%	6
IMCR	Immunocore Holdings plc	Healthcare	Biotechnology	-11.18%	—	0.00%	43
IMM.L	ImmuPharma plc	Healthcare	Biotechnology	-25.81%	-9.68%	0.00%	66
IMMP	Immutep Limited	Healthcare	Biotechnology	-87.36%	-19.51%	0.00%	11
IMMX	Immix Biopharma, Inc.	Healthcare	Biotechnology	70.94%	—	0.00%	97
IMNM	Immunome, Inc.	Healthcare	Biotechnology	1.68%	—	0.00%	95
IMNN	Imunon Inc	Healthcare	Biotechnology	-15.49%	-50.78%	0.00%	24
IMRN	Immuron Limited	Healthcare	Biotechnology	5.05%	—	0.00%	11
IMRX	Immuneering Corporation	Healthcare	Biotechnology	-17.17%	—	0.00%	89
IMTX	Immatics N.V.	Healthcare	Biotechnology	-1.43%	—	0.00%	90

Biotechnology Stock List